Trial
NCT02100956
Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Neuropathic Pain
Intervention
oxytocin 100 micrograms
Why stopped
Cessation of funding period prior to completion, due to slow recruitment during the pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-03